An unknown buyer entered into an agreement to acquire 1.1% stake in Annovis Bio, Inc. (NYSE:ANVS) for $1 million on March 15, 2024. As part of consideration, buyer will pay $8.92 in cash for each share of Annovis Bio. The parties anticipate that the closing will occur as soon as possible after the satisfaction of all of the conditions to closing including, without limitation, the listing of the Common Shares on the NYSE.

Mitchell S. Nussbaum of Loeb & Loeb LLP acted as legal advisor to Annovis Bio, Inc. Janice Santiago of Equiniti Trust Company acted as transfer agent to Annovis Bio. Michael A. Adelstein of Kelley Drye & Warren acted as legal advisor to buyer.